U.S. markets open in 4 hours 3 minutes
  • S&P Futures

    3,862.50
    -60.25 (-1.54%)
     
  • Dow Futures

    31,001.00
    -439.00 (-1.40%)
     
  • Nasdaq Futures

    11,734.00
    -201.50 (-1.69%)
     
  • Russell 2000 Futures

    1,747.70
    -25.10 (-1.42%)
     
  • Crude Oil

    107.85
    -1.74 (-1.59%)
     
  • Gold

    1,824.10
    +8.20 (+0.45%)
     
  • Silver

    21.46
    -0.08 (-0.39%)
     
  • EUR/USD

    1.0491
    +0.0025 (+0.24%)
     
  • 10-Yr Bond

    2.8860
    0.0000 (0.00%)
     
  • Vix

    32.77
    +6.67 (+25.56%)
     
  • GBP/USD

    1.2373
    +0.0030 (+0.25%)
     
  • USD/JPY

    127.7680
    -0.5290 (-0.41%)
     
  • BTC-USD

    28,983.92
    -820.02 (-2.75%)
     
  • CMC Crypto 200

    644.99
    -25.69 (-3.83%)
     
  • FTSE 100

    7,271.53
    -166.56 (-2.24%)
     
  • Nikkei 225

    26,402.84
    -508.36 (-1.89%)
     

What's Next For Novavax Stock?

·4 min read
What's Next For Novavax Stock?
In this article:
  • Oops!
    Something went wrong.
    Please try again later.

Despite seeing losses of more than 50% this year and severely underperforming the market, Novavax (NASDAQ: NVAX) stock might not be finished falling. In late December 2021, the World Health Organization granted another emergency use listing for its coronavirus vaccine, but, much to the chagrin of shareholders, it failed to stop the stock's tumble. While it might not be enough to stem the stock's losses immediately, Novavax will report its fourth-quarter earnings either at the end of February or at the start of March.